Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: A randomized controlled trial

Obstetrics and Gynecology

Volumn 115, Issue 2 PART 1, 2010, Pages 344-349

  Lyell, Deirdre J ^a   Pullen, Kristin ^b   Fuh, Katherine ^b   Zamah, A Musa ^b   Caughey, Aaron B ^b   Benitz, William ^b   El Sayed, Yasser Y ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; GENTAMICIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; AUDITORY SCREENING; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FETUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; NEWBORN; NEWBORN MORBIDITY; NEWBORN SCREENING; NEWBORN SEPSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; THIRD TRIMESTER PREGNANCY;

ADULT; ANTI-BACTERIAL AGENTS; CHORIOAMNIONITIS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GENTAMICINS; HUMANS; INJECTIONS, INTRAVENOUS; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 76549096391     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181cb5c0e     Document Type: Article

References (25)

1. Lieberman E, Lang J, Richardson DK, Frigoletto FD, Heffner LJ, Cohen A. Intrapartum maternal fever and neonatal outcome. Pediatrics 2000;105:8-13.
2. Soper DE, Mayhall CG, Dalton HP. Risk factors for intraam-niotic infection: a prospective epidemiologic study. Am J Obstet Gyencol 1989;161:562-6.
3. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130-6.
4. Blume HK, Li CI, Loch CM, Koepsell TD. Intrapartum fever and chorioamnionitis as risks for encephalopathy in term newborns: a case-control study. Dev Med Child Neurol 2008; 50:19-24.
5. Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol 1988;72:823-8.
6. Locksmith GJ, Chin A, Vu T, Shattuck KE, Hankins GD. High compared with standard gentamicin dosing for chorioamnio-nitis: a comparison of maternal and fetal serum drug levels. Obstet Gynecol 2005;105:473-9.
7. Mitra AG, Whitten MK, Laurent SL, Anderson WE. A randomized, prospective study comparing once-daily gentamicin versus thrice-daily gentamicin in the treatment of puerperal infection. Am J Obstet Gynecol 1997;177:786-92.
8. Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis Suppl 1990;74:63-70.
9. Levinson ME. New dosing regimens for amnioglycoside antibiotics. Ann J Med 1992;117:693-4.
10. Barza M, Ioannidis JP, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312:338-45.
11. Del Priore G, Jackson-Stone M, Shim EK, Garfinkel J, Eich-mann MA, Frederiksen MC. A comparison of once-daily and 8-hour gentamicin dosing in the treatment of postpartum endometritis. Obstet Gynecol 1996;87:994-1000.
12. Sunyecz JA, Wiesenfeld HC, Heine RP. The pharmacokinetics of once-daily dosing with gentamicin in women with postpar-tum endometritis. Infect Dis Obstet Gynecol 1998;6:160-2.
13. Livingston JC, Llata E, Rinehart E, Leidwanger C, Mabie B, Haddad B, et al. Gentamicin and clindamycin therapy in postpartum endometritis: the efficacy of daily dosing versus dosing every 8 hours. Am J Obstet Gynecol 2003;188:149-52.
14. Lundergan FS, Glasscock GF, Kim EH, Cohen RS. Once-daily gentamicin dosing in newborn infants. Pediatrics 1999;103;6: 1228-34.
15. Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993;341:335-9.
16. Pocock SJ. Clinical Trials: a Practical Approach. New York (NY): John Wiley & Sons Ltd; 1996
17. Lazebnik N, Noy S, Lazebnik R, Hezroni Y, Amoday I, Aviram A. Gentamicin serum half-life: a comparison between pregnant and non-pregnant women. Postgrad Med J 1985;61: 979-81.
18. Zaske DE, Cipolle RJ, Strate RG, Malo JW, Koszalka MF Jr. Rapid gentamicin elimination in obstetric patients. Obstet Gynecol 1980;56:559-64.
19. Graham JM, Blanco JD, Oshiro BT, Magee KP. Gentamicin levels in pregnant women with pyelonephritis. Am J Perinatol 1994;11:40-1.
20. Mattie H, Craig WA, Pechere JC. Determinants of efficacy and toxicity of amnioglycosides. J Antimicrob Chemother 1989;24: 281-93.
21. Edwards RK, Duff P. Single additional does postpartum therapy for women with chorioamnionitis. Obstet Gynecol 2003; 102:957-61.
22. Henry DE, Cheng YW, Shaffer BL, Kaimal AJ, Bianco K, Caughey AB. Perinatal outcomes in the setting of active phase arrest of labor. Obstet Gynecol 2008;112:1109-15.
23. Rouse DJ, Landon M, Leveno KJ, Leindecker S, Varner MW, Caritis SN, et al. The Maternal-Fetal Medicine Unites cesarean registry: chorioamnionitis at term and its duration relationship to outcomes. Am J Obstet Gynecol 2004;191:211-6.
24. Beebe LA, Cowan LD, Altshuler G. The epidemiology of placental features: associations with gestational age and neonatal outcome. Obstet Gynecol 1996;87:771-8.
25. Dong Y, St Clair PJ, Ramzy I, Kagan-Hallet KS, Gibbs RS. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol 1987;70:175-82.